‘Much-needed hope’ as CRISPR gene editing therapy recommended for sickle cell disease
Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...
Sickle cell patients share delight over approval of new treatment
Sickle cell patients share delight over approval of new treatment - Health officials have approved a £1.65 million treatment ...
National Institute for Health and Care Excellence1d
Groundbreaking one-off gene therapy approved for severe sickle cell disease
People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...
What's Happening With VRTX Stock?
With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...
New sickle cell treatment approved for NHS use offers patients ‘hope of a cure’
One sickle cell patient told ITV News the new gene therapy being rolled out for use on the NHS means they "finally have something to look towards". | ITV National News ...
Yahoo Finance4d
CRISPR Therapeutics AG (CRSP)
Despite securing approval for its first marketed ... It became the first gene-editing treatment that uses the Nobel Prize-winning CRISPR technique, an impressive achievement by CRISPR Therapeutics.
Vertex In CASGEVY Reimbursement Deal With NHS England For Sickle Cell Disease Patients
Vertex Pharmaceuticals Inc. (VRTX), a commercial-stage global biotechnology company, announced Friday a reimbursement agreement with ...
The Independent2d
Sickle cell patients share delight over approval of new treatment
A cutting-edge gene therapy has been approved for NHS use for ... was the first treatment to be licensed using gene-editing tool Crispr, which earned its inventors the Nobel Prize for chemistry ...